Relay Therapeutics Inc Cash Flow-to-Debt Ratio
Relay Therapeutics Inc cash flow-to-debt ratio. Relay Therapeutics Inc (RLAY) has a Cash Flow-to-Debt Ratio of -0.89x as of March 2026, meaning its operating cash flow of $-51.11 Million could theoretically repay -1% of its total liabilities ($57.43 Million) in one year. Check Relay Therapeutics Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Relay Therapeutics Inc (2018–2025)
Cash flow-to-debt ratio of Relay Therapeutics Inc from 2018 to 2025. Historical debt coverage capacity for Relay Therapeutics Inc across 8 annual periods. Check RLAY cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Relay Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2018–2025)
Relay Therapeutics Inc cash flow-to-debt ratio by year from 2018 to 2025. Year-by-year debt coverage analysis for Relay Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Relay Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.34x | $-235.46 Million | $54.27 Million | ▼ -62.8% |
| 2024 | -2.66x | $-249.11 Million | $93.50 Million | ▲ +18.4% |
| 2023 | -3.27x | $-300.32 Million | $91.98 Million | ▼ -112.8% |
| 2022 | -1.53x | $-229.49 Million | $149.55 Million | ▼ -128.2% |
| 2021 | -0.67x | $-74.41 Million | $110.64 Million | ▲ +76.0% |
| 2020 | -2.81x | $-102.49 Million | $36.54 Million | ▼ -2332.6% |
| 2019 | -0.12x | $-66.13 Million | $573.51 Million | ▼ -41.0% |
| 2018 | -0.08x | $-44.13 Million | $539.54 Million | — |